Quadruple Marker Test

4.6 (5 reviews)

₹1599.00    ₹3300.00

 

The Quadruple Marker Test is a second-trimester (15–20 weeks) blood screening that measures four substances—AFPhCGEstriol, and Inhibin A—to assess risks for Down syndrome (trisomy 21), Edwards syndrome (trisomy 18), and neural tube defects (like spina bifida). It is a safe, optional, non-invasive, and non-diagnostic test, meaning a high-risk result indicates a need for further diagnostic tests rather than confirming a birth defect.